Back to search

Phase II trial of daily oral VP-16 in refractory small cell lung cancer: a Hoosier Oncology Group study

DOI: 10.1016/0169-5002(90)90231-a
Lung Cancer

Data up to Jan 2025

Published1990
Citations33
References0
Fields
MedicinePhysicsOncologyInternal medicineAstrobiology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

Phase II trial of daily oral VP-16 in refractory small cell lung cancer: a Hoosier… (1990) – Lung Cancer | Metascience Observatory Explorer